Dual function of eosinophils in pathogenesis and protective immunity against parasites.
The functional duality of eosinophils, involved in a protective response or in pathogenesis is illustrated in various parasitic infections. In schistosomiasis, eosinophils have been shown to mediate schistosomula killing, in the presence of antibodies. The association of eosinophil-dependent cytotoxic antibody isotypes with resistance of reinfection (IgE and IgA antibodies), whereas in vitro blocking antibody isotypes (IgG4, IgM) were detected in susceptible subjects, suggested a participation of eosinophils in antibody-dependent protective response. However eosinophils could participate to granuloma formation and consequently to the pathological reactions during schistosomiasis. Activation of eosinophils by antibodies, leading to release of granule proteins have been studied in patients with filariasis. Eosinophil peroxidase, EPO was released after IgE-dependent activation whereas Eosinophil Cationic Protein, ECP, was released after IgG- and IgA-dependent activation of eosinophils, results suggesting a process of differential release of mediators. Interactions between eosinophils and interleukins, and specially IL-5 are discussed. Whereas a receptor for IL-5 has been characterized on human eosinophils, recent studies have shown that eosinophils expressed the messenger RNA encoding IL-5. These results associated to data showing the synthesis of other cytokines indicate that eosinophils are not only the source of cytotoxic mediators involved in the effector phase of immunity but also of growth and regulatory factors, participating to immunoregulation.
Capron
M
M
Centre d'Immunologie et de Biologie Parasitaire, Unité Mixte INSERM U 167, CNRS 624, Institut Pasterur, Lille, France.
D000818:Animals; D000909:Antibodies, Helminth / Q000276:immunology; D000920:Antibody-Dependent Cell Cytotoxicity; D004802:Eosinophilia / Q000209:etiology; D004804:Eosinophils / Q000502:physiology*; D005368:Filariasis / Q000276:immunology; D006099:Granuloma / Q000276:immunology; D006801:Humans; D015848:Interleukin-5 / Q000235:genetics / Q000502:physiology; D051379:Mice; D010272:Parasitic Diseases / Q000150:complications / Q000276:immunology*; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D018123:Receptors, Interleukin / Q000502:physiology; D053649:Receptors, Interleukin-5; D012552:Schistosomiasis / Q000150:complications / Q000276:immunology
D000909:Antibodies, Helminth; D015848:Interleukin-5; D012333:RNA, Messenger; D018123:Receptors, Interleukin; D053649:Receptors, Interleukin-5